Nordicus Partners (NORD) Liabilities and Shareholders Equity (2011 - 2026)
Nordicus Partners (NORD) recorded Liabilities and Shareholders Equity of $73.1 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 4.0% from $76.12 million a year earlier and down 3.1% from the prior quarter.
Powered by 
Analysis
Nordicus Partners (NORD) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Nordicus Partners reported Liabilities and Shareholders Equity of $75.46 million, up 7.4% from FY2025.
- Annual Liabilities and Shareholders Equity has a five-year compound annual growth rate of 258.2% (FY2021 to FY2026).
- Across earlier fiscal years, Liabilities and Shareholders Equity came in at $70.25 million in FY2025, $1.81 million in FY2024, $55,025 in FY2023 (-78.0%) and $250,000 in FY2022 (+95.3%).
- The fiscal Q1 2027 figure is the lowest quarterly Liabilities and Shareholders Equity since fiscal Q4 2025.
- On a year-over-year basis, Liabilities and Shareholders Equity rose in four of the last five quarters, with growth averaging 112.3%.
- Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 849.7% in fiscal Q1 2024, against a decline of 99.3% in fiscal Q2 2022 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $75.46 million (Q4 2026), $75.86 million (Q3 2026) and $75.88 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Nordicus Partners | 78.16 Mn | 77.63 Mn | - | 73.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 73.10 Mn |
| Mar 31, 2026 | 75.46 Mn |
| Dec 31, 2025 | 75.86 Mn |
| Sep 30, 2025 | 75.88 Mn |
| Jun 30, 2025 | 76.12 Mn |
| Mar 31, 2025 | 70.25 Mn |
| Dec 31, 2024 | 59.72 Mn |
| Sep 30, 2024 | 20.79 Mn |
| Jun 30, 2024 | 20.80 Mn |
| Mar 31, 2024 | 1.81 Mn |
| Dec 31, 2023 | 1.80 Mn |
| Sep 30, 2023 | 1.77 Mn |
| Jun 30, 2023 | 1.79 Mn |
| Mar 31, 2023 | 55,025.00 |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Jun 30, 2022 | 188,000.00 |
| Mar 31, 2022 | 250,000.00 |
| Dec 31, 2021 | 122,000.00 |
| Sep 30, 2021 | 3,000.00 |
API Access
Nordicus Partners Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NORD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "NORD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NORD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();